A short guide to therapeutic antibody patenting.

5. maj 2015

Article written by Janni Wandahl Pedersen

Therapeutic antibodies have become an established class of drugs for the treatment of a variety of diseases, especially cancer and autoimmune/inflammatory disorders, and a sufficient patent protection is a prerequisite for their successful commercialisation.

Please click here to read the full article.